Israel achieves up to 90% success rates in oncology by integrating AI-guided thermal ablation and SIRT therapies. Patients access specialist consultations within days. Major centers like Sourasky Medical Center serve 400,000+ patients annually. Highly trained surgeons prioritize liver-sparing techniques to preserve organ function for every patient.
- Success rates: Oncology centers like Sourasky report 90% success rates using personalized diagnostic strategies.
- AI-guided precision: BioTraceIO AI provides real-time guidance during thermal ablation to protect healthy tissue.
- Surgical volume: Major hospitals operate at scale. Sourasky Medical Center performs 34,000+ operations every year.
- Specialized expertise: Surgeons like Dr. Menahem Ben-haim offer 28+ years of experience in liver cancer.
Bookimed Expert Insight: Israel’s leading oncology departments, such as Hadassah, operate as multidisciplinary university centers. These facilities often provide access to experimental protocols and molecular genetic profiling. This depth of research allows doctors to tailor treatments for complex Stage 2 cases effectively. Patients benefit from 2,200+ doctors in a single facility like Sourasky.
What patients say: Patients note it's important that treatment planning begins rapidly after seeing hepatologists within days. The focus in Israel stays on liver-sparing techniques and clear communication in English. Many find the standard use of bridging therapies helps prevent tumor progression before their surgery.